Skip to main navigation Skip to search Skip to main content

Emergence of carbapenem-resistant ST131 escherichia coli carrying blaOXA-244 in germany, 2019 to 2020

Sybille Welker, Sébastien Boutin, Thomas Miethke, Klaus Heeg, Dennis Nurjadi*

*Corresponding author for this work

Abstract

The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 Escherichia coli in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing E. coli may be underreported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 E. coli is of clinical relevance and should be monitored closely.

Original languageEnglish
JournalEurosurveillance
Volume25
Issue number46
ISSN1025-496X
DOIs
Publication statusPublished - 11.2020

Funding

FundersFunder number
UK Research and Innovation106157

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Research Areas and Centers

    • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

    DFG Research Classification Scheme

    • 2.21-03 Medical Microbiology and Mycology, Hygiene, Molecular Infection Biology
    • 2.21-05 Immunology

    Fingerprint

    Dive into the research topics of 'Emergence of carbapenem-resistant ST131 escherichia coli carrying blaOXA-244 in germany, 2019 to 2020'. Together they form a unique fingerprint.

    Cite this